Company Filing History:
Years Active: 2025
Title: Sudeh Izadmehr: Innovator in Bicyclic Inhibitors
Introduction
Sudeh Izadmehr is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific proteins.
Latest Patents
Izadmehr holds a patent for "Bicyclic inhibitors of CBX chromodomains." This patent discloses a genus of bicyclic inhibitors of CBX chromodomains. The compounds are characterized by the presence of carbon or nitrogen, resulting in structures that are either indoles or benzimidazoles. A notable subgenus includes 1,3-disubstituted-1,3-dihydro-2H-benzo[d]imidazol-2-imines, which are designed to inhibit CBX proteins. He has 1 patent to his name.
Career Highlights
Sudeh Izadmehr is affiliated with the Icahn School of Medicine at Mount Sinai, where he conducts research and develops innovative solutions in his field. His work has the potential to impact therapeutic strategies significantly.
Collaborations
Izadmehr collaborates with Ming-Ming Zhou, contributing to advancements in their shared research interests.
Conclusion
Sudeh Izadmehr is a dedicated inventor whose work on bicyclic inhibitors showcases his commitment to advancing medicinal chemistry. His contributions are paving the way for future innovations in the field.